Welcome back to Higher Law, our weekly briefing on all things cannabis. I’m Cheryl Miller, reporting for Law.com from Sacramento. I took a quick trip to New York City last week and while paying for my roast beef sandwich at a deli I spotted a stack of CBD-infused brownies for sale next to the cash register. Good thing Scott Gottlieb wasn’t with me. (More on that below.)
This week we look at a flurry of FDA activity on cannabis-infused products. Then, the States Act has been revived. Will its promised protections for marijuana-legal states be any more successful this year? And scroll down to see who got the work.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
